Sinobiopharma, Inc. received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material from the SFDA. Gabexate mesylate is a serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. We look at Sinobiopharma's business. More details...

Stock Symbol: (OTCBB: SNBP)